Optiver Holding B.V. purchased a new stake in Genmab A/S (NASDAQ:GMAB – Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 96,269 shares of the company’s stock, valued at approximately $3,635,000. Other institutional investors have also added to or reduced their stakes in […]
Genmab A/S (NASDAQ:GMAB – Free Report) – Stock analysts at HC Wainwright dropped their Q1 2024 earnings estimates for shares of Genmab A/S in a note issued to investors on Monday, July 31st. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings of $0.07 per share for the quarter, down from […]
A number of firms have modified their ratings and price targets on shares of Genmab A/S (NASDAQ: GMAB) recently: 7/31/2023 – Genmab A/S had its “underweight” rating reaffirmed by analysts at Morgan Stanley. 7/31/2023 – Genmab A/S had its “buy” rating reaffirmed by analysts at HC Wainwright. 7/24/2023 – Genmab A/S had its “underweight” rating […]
LVW Advisors LLC lowered its position in Genmab A/S (NASDAQ:GMAB – Free Report) by 3.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 17,111 shares of the company’s stock after selling 633 shares during the quarter. LVW Advisors LLC’s holdings in Genmab A/S […]
Venturi Wealth Management LLC boosted its holdings in Genmab A/S (NASDAQ:GMAB – Free Report) by 9.6% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 24,409 shares of the company’s stock after buying an additional 2,140 shares during the quarter. Venturi Wealth Management LLC’s holdings […]